Skip to main content
Loading Events

« All Events

Academic Resilience: Strengthening Your Research by Leveraging Rejection

May 12 @ 12:00 pm - 1:00 pm

In keeping with policies resulting from COVID-19, this program will be only offered via Zoom.

Academic Resilience: Strengthening Your Research by Leveraging Rejection

 12:00 pm – 1:00 p.m., Wednesday, May 12, 2021, via Zoom

What do you do when your work gets rejected? In this panel session, successful scholars from various divisions at the School will discuss how they leverage academic rejection to strengthen their work. At the end of this session, participants will be able to describe how and why research rejection happens in academia, reflect on their own experiences with peer review, and identify strategies for addressing rejection within their own research.

Learning Objectives:

At the end of this program, participants will be able to:

  1. Describe how and why research rejection happens in academia
  2. Reflect on their own experiences with academic rejection
  3. Identify strategies for addressing rejection within their own research

Target Audience:  This program is designed for all faculty, staff, preceptors, students and trainees who lead or collaborate on research projects.

Registration:  Non-UNC affiliates will pay a registration fee of $15.00.

REGISTRATION DEADLINE:  Friday, May 7, at 5 p.m.

To Register Click Here

jacqui mclaughlinJacqui McLaughlin, PhD, Associate Professor & Director of CIPhER, UNC Eshelman School of Pharmacy

Jacqui McLaughlin, PhD, received her undergraduate degree in biological engineering from North Carolina State University, her master of science in biomedical engineering from the University of Memphis/University of Tennessee, and her doctorate in educational research and policy analysis from North Carolina State University. She spent one year as a postdoctoral fellow with the Office of Strategic Planning and Assessment (OSPA) at the UNC Eshelman School of Pharmacy and currently serves the school as an associate professor in the division of Practice Advancement and Clinical Education and as the director of CIPhER. Dr. McLaughlin has published more than 50 peer-reviewed articles about higher education, is on the editorial board for the journals Currents in Pharmacy Teaching and Learning and Education in the Health Professions and serves as associate editor for BMJ Medical Education. Her published research spans a wide range of education topics, including admissions, flipped classrooms, experiential education, student organizations, diversity, graduate training, cognitive apprenticeship, and research methodology.


Panelist Information

kristy_ainslieKristy Ainslie, PhD, Vice Chair, & Professor, Division of Pharmacoengineering and Molecular Pharmaceutics, UNC Department of Biomedical Engineering, UNC Department of Microbiology and Immunology

Kristy Ainslie, PhD applies her knowledge base in biomaterials, and immunology to develop new immune-modulatory therapies that treat and prevent infectious and autoimmune diseases. Her lab aims to design practical and innovative formulations, taking into account the scalable production and applications in developing nations.  She has several research areas of interest including the development of new polymers for vaccines, formulation of antigen specific therapies to treat autoimmune diseases like multiple sclerosis and type 1 diabetes, host directed therapies for treatment of multi-drug resistant infections, electrospun scaffolds for glioblastoma treatment, and electrospray for fabrication of immune targeting microparticles.  Originally from Michigan, she received her bachelor of science in chemical engineering from Michigan State University and then earned both her master’s and Ph.D. in chemical engineering from Pennsylvania State University. She completed a postdoctoral fellowship at the University of California at San Francisco. Additionally, Dr. Ainslie has been awarded the Controlled Release Society’s Outstanding Oral Drug Delivery Award in 2007 and 2009. She joined the UNC Eshelman School of Pharmacy in 2014 as an associate professor in the Division of Pharmacoengineering and Molecular Pharmaceutics. Prior to that, she spent almost five years as an assistant professor at the Ohio State University’s Division of Pharmaceutics and Pharmaceutical Chemistry.


jeff_aubeJeff Aubé, PhD, Distinguished Professor, Center for Integrative Chemical Biology and Drug Discovery & Professor, UNC Department of Chemistry

Jeffrey Aubé, PhD, joined the UNC Eshelman School of Pharmacy faculty as a Professor in the Division of Chemical Biology and Medicinal Chemistry in the summer of 2015. In addition to holding a joint appointment in the Department of Chemistry, Aubé is a member of the Center for Integrative Chemical Biology and Drug Discovery and the Lineberger Comprehensive Cancer Center.  Before joining the School, Aubé was a professor at the University of Kansas where he served as the director of their Chemical Methodologies and Library Development Center and their Specialized Chemistry Center. Aubé has authored more than 250 publications, received more than twenty research and teaching awards, and has been invited to give more than 300 lectures.


kim brouwerKim Brouwer, PharmD, PhD, Associate Dean & William R. Kenan, Jr. Distinguished Professor, UNC Eshelman School of Pharmacy

Kim L.R. Brouwer, PharmD, PhD, is a William R. Kenan, Jr., Distinguished Professor in the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy, associate dean for research and graduate education, and a professor in the curriculum in toxicology.  Brouwer received her B.S. in pharmacy from Oregon State University. She completed her Pharm.D. at the University of Kentucky (UK) College of Pharmacy in conjunction with a pharmacy residency at the UK Medical Center and a PhD in pharmaceutical sciences/pharmacokinetics. After postdoctoral training (pharmacology/drug metabolism) in the UK College of Medicine, she joined the faculty at the University of North Carolina in 1986, where she served as director of graduate studies for the UNC Eshelman School of Pharmacy from 1996 to 2004, and Chair of the Division of Pharmacotherapy and Experimental Therapeutics from 2004 to 2015.  Brouwer directs an NIH-funded research program focused on hepatobiliary drug disposition and development and refinement of in vitro model systems to predict in vivo hepatobiliary disposition, drug interactions, and hepatotoxicity. She has mentored more than 104 undergraduate, professional, graduate and postdoctoral students and published more than 230 research papers, reviews and book chapters in addition to more than 240 published abstracts.  Brouwer is also a co-inventor of B-CLEAR® (U.S. Patent No. 6,780,580), an in vitro method to assess hepatic uptake, excretion, and biliary clearance that correlates with in vivo data. This technology has been exclusively licensed from the University of North Carolina at Chapel Hill to Qualyst, Inc. Brouwer is a Qualyst co-founder and former chair of the company’s scientific advisory board. Qualyst Transporter Solutions was acquired by BioIVT in August 2017.  She served as a member of the NIH Pharmacology Study Section from 1998 to 2002, and is a member of the editorial advisory boards for Clinical Pharmacology and Therapeutics, CPT Pharmacometrics & Systems Pharmacology, Clinical and Translational Science, and the AAPS Journal. She was elected an AAPS Fellow in 1998, was recipient of the PHRMA Foundation Award in Excellence in Pharmaceutics in 2001, received the inaugural Pharmaceutical Sciences Outstanding Graduate Program Alumni Award and the Paul F. Parker Award from the University of Kentucky, and was the recipient of the 2018 ASCPT-FDA Abrams Award.


Stephen Eckel, PharmD, MHA, Associate Dean for Global Engagement & Associate Professor UNC Eshelman School of Pharmacy

Stephen Eckel, PharmD, MHA, is associate dean for global engagement and an associate professor in the Division of Practice Advancement and Clinical Education. In addition, he is program director of the two-year Master of Science in Pharmaceutical Sciences with a specialization in health-system pharmacy administration. This degree is hosted at multiple sites across the US. At UNC Medical Center, he is program director of a 2-year residency in health-system pharmacy administration.  As an innovator and entrepreneur Eckel spearheaded the development of UNC Pharmacy Grand Rounds with ASHP and launched ChemoGLO, LLC with Bill Zamboni, PharmD, PhD. He also founded Assure Technologies, LLC, which is developing the Precynge medical device. He is the previous editor of the health-system edition of Pharmacy Times and a passionate supporter of the role of the pharmacist and the use of technology in patient care. He conducts and publishes his research and is frequently asked to speak around the world on these issues.  Eckel has been very active in the North Carolina Association of Pharmacists, serving in the past as President. He is a past member of the Board of Directors of American Society of Health-System Pharmacists. In 2012, he was presented by APhA the Distinguished Achievement Award in Hospital and Institutional Practice and in 2013, he was awarded the Excellence in Innovation award by NCAP. In 2015, the ASHP Foundation awarded him the Pharmacy Residency Excellence Preceptor Award. He is a Fellow of ASHP, APhA, ACCP, and the National Academies of Practice in Pharmacy.


Betsy_SleathBetsy Sleath, PhD, Regional Associate Dean – Eastern North Carolina, George H. Cocolas Distinguished Professor, Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy & Director of Child and Adolescent Health Program, Cecil G. Sheps Center

Betsy Sleath, PhD, is the Regional Associate Dean for Eastern North Carolina and the George H Cocolas Distinguished Professor in the Division of Pharmaceutical Outcomes and Policy in the UNC Eshelman School of Pharmacy. She is a senior research fellow and director of the Child and Adolescent Health Program at the Cecil G Sheps Center for Health Services Research. She is also an adjunct professor of health policy and management and epidemiology at the UNC Gillings School of Global Public Health. She is principal investigator on a 1.6 million dollar grant “Improving African American Glaucoma Patient Involvement in Visits and Outcomes.”  Sleath teaches ethics, communications and research methods. She teaches in several PharmD courses and she coordinates the grant/proposal writing course for graduate students from several divisions in the school.


Event FAQ

  • A Zoom link will be provided prior to the session via a confirmation Outlook invitation. For CE purposes, if your login to Zoom is different from your name, please send an email to with details.



May 12
12:00 pm - 1:00 pm
Event Category: